Globe Newswire

To Nasdaq Copenhagen

Terms for Nykredit's and Totalkredit's auctions

The total bond offering in connection with the interest rate adjustment of adjustable-rate mortgages (ARMs) and the refinancing of floating-rate loans at Nykredit’s and Totalkredit’s refinancing auctions amounts to approx. DKK 36.2bn. The auctions will be conducted in the period from 21st to 24th May 2024.

In the auction period, Nykredit Realkredit A/S will publish the amounts offered in the... (continue reading...)

To Nasdaq Copenhagen   

Terms for Nykredit's and Totalkredit's auctions

The total bond offering in connection with the interest rate adjustment of adjustable-rate mortgages (ARMs) and the refinancing of floating-rate loans at Nykredit’s and Totalkredit’s refinancing auctions amounts to approx. DKK 36.2bn. The auctions will be conducted in the period from 21st to 24th May 2024.

In the auction period, Nykredit Realkredit A/S will publish the amounts offered in... (continue reading...)

CALGARY, Alberta, May 03, 2024 (GLOBE NEWSWIRE) --

TransAlta Corporation (“TransAlta” or the “Company”) (TSX: TA) (NYSE: TAC) today reported its financial results for the first quarter ended March 31, 2024, demonstrating strong operational and financial performance and reaffirming its 2024 outlook.

First Quarter 2024 Financial Highlights

TransAlta’s first quarter results exceeded our expectations given the anticipated decline in Alberta spot power prices... (continue reading...)

EDINBURG, Va., May 03, 2024 (GLOBE NEWSWIRE) -- Shenandoah Telecommunications Company (“Shentel” or the “Company”) (Nasdaq: SHEN) announced first quarter 2024 financial and operating results.

Tower segment’s financial results will be presented as discontinued operations in the Company’s Consolidated Financial Statements. Under the new organizational and reporting structure, the Company has one reportable segment in continuing operations.

First... (continue reading...)

TOKYO, LONDON and BOSTON, May 03, 2024 (GLOBE NEWSWIRE) -- Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, today announced that Bobby Gaspar, M.D., Ph.D., co-founder and chief executive officer, has been named to the inaugural 2024 TIME100 Health, an annual list recognizing the impact, innovation, and achievement of the world’s most influential individuals in health... (continue reading...)